#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Measles Hydrocephalus Nephropathy Heritable pulmonary arterial hypertension Amyotrophic lateral sclerosis Chronic lymphocytic leukaemia recurrent Acquired ATTR amyloidosis Autoimmune hepatitis Liposarcoma Neovascular age-related macular degeneration Gastrooesophageal cancer Graft versus host disease Monogenic diabetes Advanced systemic mastocytosis Pericarditis More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Treatment Hepatoblastoma – Life with Disease Glomerulonephritis membranoproliferative – Treatment Cholangitis sclerosing – Life with Disease Rosai-Dorfman syndrome Usher’s syndrome – Basic Information Cystic fibrosis – Trials in Disease Kearns-Sayre syndrome – Diagnostics Mucous membrane pemphigoid – Trials in Disease Bronchopulmonary dysplasia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amg 193 Pregabalin Demeclocycline Hydrochloride Emicizumab Murcidencel Ds-3939A TRIMIPRAMINE MALEATE Lasmiditan Treprostinil Epcoritamab Eribulin Sabirnetug Cisatracurium Besilate Dirocaftor Copanlisib Dihydrochloride MARALIXIBAT ANXV Tadalafil Dabrafenib Acp-204 Tartrate More therapies…

    Learn about Your Condition

    Testicular germ cell tumour Malignant glioma Synovitis Thalassaemia alpha Hypersensitivity Myocardial infarction Immunodeficiency congenital Pleural mesothelioma Exfoliation glaucoma Anal cancer stage III Ovarian cancer stage IV Oesophageal achalasia Conjunctivitis Malignant mast cell neoplasm Osteoporosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study comparing azithromycin with cefuroxime versus cefuroxime alone for preventing infections in patients undergoing hysterectomy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hysterectomy
    Investigated Drugs:
    • Azithromycin
    Finland

  • Study on Rituximab for Patients with Mental Disorders and Autoimmunity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mental disorder
    Investigated Drugs:
    • Rituximab
    France

  • Study on Donepezil Versus Non-drug Treatment for Patients with Alzheimer’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Donepezil
    France

  • Study of Early versus Delayed Treatment with Azathioprine or Rituximab in Children with Anti-MOG Antibody Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myelin oligodendrocyte glycoprotein antibody-associated disease
    Investigated Drugs:
    • Azathioprine
    • Methylprednisolone
    • Prednisolone
    France

  • Study on Oral Propranolol for Preventing Severe Retinopathy in Premature Infants

    Recruiting

    2 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Propranolol Hydrochloride
    Germany

  • Study on Glioblastoma Treatment with Metformin, Temozolomide, and Radiotherapy for Newly Diagnosed Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    • Glioblastoma
    Investigated Drugs:
    • Metformin Hydrochloride
    • Temozolomide
    France
Previous Page
1 … 625 626 627 628 629 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!